Institute of Pathology

Salivary Gland Carcinoma in Children and Adolescents: The Expert/Partner Diagnosis and Treatment Recommendations (2021) Bisogno G, Schneider D, Ferrari A, Stachowicz-Stencel T, Rascon J, Synakiewicz A, Agaimy A, et al. Conference contribution The challenge of undifferentiated malignancies: Phenotype versus genotype! What matters most? (2021) Agaimy A Journal article, Review article Pleomorphic (giant cell) carcinoma revisited: A historical perspective and conceptual reappraisal (2021) Agaimy A Journal article, Review article Cell-free dna variant sequencing using plasma and ar-v7 testing of circulating tumor cells in prostate cancer patients (2021) Lieb V, Bellut L, Abdulrahman A, Weigelt K, Hauch S, Gombert M, Guzman J, et al. Journal article Variable expression of the disialoganglioside gd2 in breast cancer molecular subtypes (2021) Erber R, Kailayangiri S, Hübner H, Rübner M, Hartmann A, Häberle L, Meyer J, et al. Journal article Tetraspanin 5 (Tspan5), a novel gatekeeper of the tumor suppressor dlc1 and myocardin-related transcription factors (mrtfs), controls hcc growth and senescence (2021) Schreyer L, Mittermeier C, Franz M, Meier M, Martin DE, Maier KC, Hübner K, et al. Journal article Recurrent YAP1-TFE3 Gene Fusions in Clear Cell Stromal Tumor of the Lung (2021) Agaimy A, Stöhr R, Michal M, Christopoulos P, Winter H, Zhang L, Stenzinger A, et al. Journal article Gelatin methacryloyl is a slow degrading material allowing vascularization and long-term use in vivo (2021) Heltmann-Meyer S, Steiner D, Mueller C, Schneidereit D, Friedrich O, Salehi S, Engel F, et al. Journal article, Original article Predictive Value of Multiparametric MRI for Response to Single-Cycle Induction Chemo-Immunotherapy in Locally Advanced Head and Neck Squamous Cell Carcinoma (2021) Hellwig K, Ellmann S, Eckstein M, Wiesmüller M, Rutzner S, Semrau S, Frey B, et al. Journal article A Possible Distinct Molecular Subtype (Quintuple-Wildtype) of Metastatic Colorectal Cancer in First-Line Anti-EGFR Therapy with Cetuximab Plus FOLFIRI - Palliative Precision Therapy and a Multidisciplinary Treatment Approach: Interim Analysis of the IVOPAK II Trial with Early Results (2021) Wein A, Stöhr R, Kersting S, Siebler J, Merkel S, Busse D, Wolff K, et al. Journal article